Oculogica
New York, US · Founded 2013 · Delaware corporation · 14 employees on LinkedIn · 5 known investors
Oculogica develops FDA-cleared concussion assessment devices that use proprietary eye-tracking technology to measure abnormal eye movements caused by traumatic brain injury. Its tools serve clinicians and athletic trainers across settings including sports sidelines, pediatric and urgent care clinics, accident/personal injury clinics, and military care.
Founders & leadership
Oculogica was founded in 2013 by Rosina Samadani and Uzma Samadani.
RS
Rosina SamadaniCo-founder
US
Uzma SamadaniinCo-founder
PL
Pratipatti LaxminarainNamed on SEC filing
JH
Jason HuangNamed on SEC filing
RR
Robert RitlopNamed on SEC filing
BK
Bilal KhanNamed on SEC filing
Board
KS
Investors · 5
Colle Capital PartnersNew York · $500K – $2M
Seraph GroupMilton · $50K – $2M
TitletownTechGreen Bay · $100K – $2Mvia Jill Enos · board
Golden SeedsreportedFlushing · $250K – $2M
Also in the syndicate · 1
Microsoft
Reported raises · per SEC filings
Form D private placements$22M disclosed across 5 rounds · 2014–2024
▶$7.6MraisedMay 2024 · 24 investors · BiotechnologyRule 506(b)
▶$7.6MraisedMay 2024 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim FlanniganDirector
- Kathryn SwintekDirector
- Rosina SamadaniExecutive Officer, Director
- Pratipatti LaxminarainDirector
- Jill EnosDirector
- Uzma SamadaniDirector
- Offering amount
- $18M
- Amount sold
- $7.6M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4MraisedJun 2022 · 20 investors · Other Health CareRule 506(b)
▶$4MraisedJun 2022 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jill EnosDirector
- Kathryn SwintekDirector
- Uzma SamadaniDirector
- Pratipatti LaxminarainDirector
- Rosina SamadaniExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $4M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.1MraisedJan 2020 · 41 investors · Other Health CareRule 506(b)
▶$8.1MraisedJan 2020 · 41 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jill EnosDirector
- Rosina SamadaniExecutive Officer, Director
- Uzma SamadaniDirector
- Kathryn SwintekDirector
- Pratipatti LaxminarainDirector
- Offering amount
- $8.6M
- Amount sold
- $8.1M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedMar 2016 · 8 investors · BiotechnologyRule 506(b)
▶$1.7MraisedMar 2016 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rosina SamadaniExecutive Officer
- Bilal KhanDirector
- Uzma SamadaniDirector
- Jason HuangDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$600KraisedJul 2014 · 6 investors · BiotechnologyRule 506(b)
▶$600KraisedJul 2014 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason HuangDirector
- Uzma SamadaniDirector
- Robert RitlopExecutive Officer
- Bilal KhanDirector
- Offering amount
- $1000K
- Amount sold
- $600K
- First sale
- May 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Sway Medical20 shared keywordsSway offers a mobile app that uses built-in phone sensors to run objective balance, cognitive, and functional assessments, including concussion baseline and sideline testing. It is used by athletic trainers, physical therapists, and other healthcare providers for sports and clinical use cases.
Hackensack19 shared keywordsHackensack Meridian Health is a hospital network in New Jersey providing clinical services including neurology and neurosurgery, orthopedics, behavioral health, virtual and urgent care, and cancer care. It also operates medical education and research programs, and runs health and wellness centers across the state.
Companies competing with Oculogica for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $553.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Oculogica do?
- Oculogica develops FDA-cleared concussion assessment devices that use proprietary eye-tracking technology to measure abnormal eye movements caused by traumatic brain injury. Its tools serve clinicians and athletic trainers across settings including sports sidelines, pediatric and urgent care clinics, accident/personal injury clinics, and military care.
- Who founded Oculogica?
- Oculogica was founded by Rosina Samadani, Uzma Samadani in 2013.
- Who are Oculogica's investors?
- Oculogica's investors include Colle Capital Partners, Seraph Group, TitletownTech, Golden Seeds.
- How much funding has Oculogica raised?
- Oculogica has disclosed $22M raised across 5 rounds.
- Where is Oculogica headquartered?
- Oculogica is headquartered in New York, US.